Drug Pricing

Letter to Secretary Becerra about Policies & Solutions to Improve Prescription Drug Affordability for Patients

We, the undersigned 124 organizations, on behalf of millions of patients and American consumers who live with complex conditions such as HIV, autoimmune diseases, cancer, diabetes, lupus, multiple sclerosis, and hepatitis, write to congratulate you on becoming Secretary and express our deep commitment and interest in working with you, the Department of Health and Human Services (HHS), and the Biden administration to implement policies and measures that improve prescription drug affordability and access for the American people.

read more

Comments on NAIC draft pharmacy benefit manager model law

The HIV+HEP Policy Institute, a leading HIV and hepatitis policy organization promoting quality and affordable healthcare for people living with or at risk of HIV, hepatitis, and other serious and chronic health conditions, is pleased to submit comments on the draft NAIC Pharmacy Benefits Manager (PBM) Model Law…

read more

Comments on transparency in coverage proposed rule

The HIV+Hepatitis Policy Institute, a new national, non-profit organization whose mission is to promote quality and affordable healthcare for people living with or at risk of HIV, hepatitis, and other serious and chronic health conditions, is pleased to submit comments on the proposed rule to increase price transparency…

read more

Pin It on Pinterest